Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,261,199 papers from all fields of science
Search
Sign In
Create Free Account
efalizumab
Known as:
anti alphaL integrin
, antiCD11 alpha
, efalizumab [Chemical/Ingredient]
A humanized IgG1 monoclonal antibody directed against CD11a, the alpha subunit of human leukocyte-function-associated antigen type 1 (LFA-1), with…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Monoclonal Antibodies
antigen binding
hu1124
Narrower (1)
Raptiva
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
B. van Oosten
,
J. Killestein
,
F. Barkhof
,
C. Polman
,
M. Wattjes
New England Journal of Medicine
2013
Corpus ID: 27819488
Two cases of progressive multifocal leukoencephalopathy (PML) are reported in patients with psoriasis who were treated with…
Expand
Highly Cited
2012
Highly Cited
2012
Fatal PML associated with efalizumab therapy
N. Schwab
,
J. Ulzheimer
,
+13 authors
H. Wiendl
Neurology
2012
Corpus ID: 207120776
Objectives: Progressive multifocal leukoencephalopathy (PML) has become much more common with monoclonal antibody treatment for…
Expand
Highly Cited
2012
Highly Cited
2012
Marketed therapeutic antibodies compendium
J. Reichert
mAbs
2012
Corpus ID: 28297692
Therapeutic monoclonal antibodies (mAbs) are currently being approved for marketing in Europe and the United States, as well as…
Expand
Review
2010
Review
2010
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies.
E. Major
Annual Review of Medicine
2010
Corpus ID: 32039937
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the white matter of the human brain caused by…
Expand
Review
2009
Review
2009
Treatments for psoriasis and the risk of malignancy.
Rita V. Patel
,
Lily N Clark
,
M. Lebwohl
,
J. Weinberg
Journal of American Academy of Dermatology
2009
Corpus ID: 1681873
Review
2009
Review
2009
Therapeutic monoclonal antibodies in ophthalmology
E. Rodrigues
,
M. Farah
,
+5 authors
C. R. Zanetti
Progress in retinal and eye research
2009
Corpus ID: 8226160
Highly Cited
2004
Highly Cited
2004
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.
Christopher S Carlin
,
S. Feldman
,
J. Krueger
,
A. Menter
,
G. Krueger
Journal of American Academy of Dermatology
2004
Corpus ID: 24921979
Highly Cited
2003
Highly Cited
2003
Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.
X. Zhou
,
J. Krueger
,
+5 authors
A. Bowcock
Physiological Genomics
2003
Corpus ID: 468634
A global picture of gene expression in the common immune-mediated skin disease, psoriasis, was obtained by interrogating the full…
Expand
Highly Cited
2002
Highly Cited
2002
Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.
A. Gottlieb
,
J. Krueger
,
K. Wittkowski
,
R. Dedrick
,
P. Walicke
,
M. Garovoy
Archives of Dermatology
2002
Corpus ID: 33618096
BACKGROUND Leukocyte function-associated antigen 1 (LFA-1), consisting of CD11a and CD18 subunits, plays an important role in T…
Expand
Highly Cited
1975
Highly Cited
1975
Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture.
N. Iscove
,
F. Sieber
Experimental Hematology
1975
Corpus ID: 31394091
Methods for the cultivation of erythroid colonies in vitro are expected to allow selective assay of the earliest committed…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE